Original filing was Dec/2nd with a 6 month review would have given June/2nd as the PDUFA date. Normal extensions are for 3 months so that gives Sept/2nd as the new PDUFA date but its not set in stone.
I work in the real life. I've been in plenty of emergency situations & deal with individuals who've had ischemic events. Emergency workers are not going to haphazardly give the drug.
Hofono, is clueless about how it would be used. Googling something will only tell you so much.
If midazolam was the wrong treatment then it still does no harm in the dosage that would be used. What harm would midazolam due in a hypoxic-ischemic event? If you gave 5 mg SQ then it wouldn't do anything more then give some sedation.
You could use the midazolam injector like the epi-pen. Available for emergency situations if a person has a history of seizures or stored on emergency vehicles.
I said QSM was going to be midazolam a long time ago. Studies have shown its the best emergency drug for seizures.
3 or 4 cent spike came from. First one in - first one out mentality.
I'm not feeling brilliant. I sold my ARWR shares yesterday, booked a decent gain but then an analyst picked them as a buyout target last night & its trading up $1.60 a share today.
The market cap reflects its true value. Any positive developments from Otrexup, QST, or Epi-pen should move it higher instead of fading back down.
I can't remember the details but ATRS screwed this up 15 yrs ago. They were partnered with PFE for a insulin injector & the partnership abandoned.